A Phase II Trial of Neoadjuvant Chemotherapy with Genexol® (Paclitaxel) and Epirubicin for Locally Advanced Breast Cancer

PURPOSE: Neoadjuvant chemotherapy (NC) is yet to be established as the definitive treatment regimen for locally advanced breast cancer (LABC). The aim of this study was to determine the efficacy and toxicity of NC with epirubicin and paclitaxel. METHODS: Between March 2007 and January 2009, 50 patie...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Breast Cancer
Autori principali: Lee, Jinsun, Kim, Jeryong, Chang, Eilsung, Choi, Woonjung, Lee, Kwangman, Yoon, Hyunjo, Jung, Sunghoo, Park, Minho, Yoon, Junghan, Kim, Sungyong
Natura: Artigo
Lingua:Inglês
Pubblicazione: Korean Breast Cancer Society 2014
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4278053/
https://ncbi.nlm.nih.gov/pubmed/25548582
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4048/jbc.2014.17.4.344
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi